Colchicine in tear fluid of treated patients with familial Mediterranean fever

Igal Leibovitch, Yair Alster, Jean Michel Scherrmann, Barak Azmon, Irina S. Barequet, Avi Livneh, Terrence P. O'Brien, Moshe Lazar, Anat Loewenstein

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Purpose. The study aimed to determine whether detectable concentrations of colchicine are present in the tear fluid of treated patients with familial Mediterranean fever (FMF) and thus demonstrate a possible route by which colchicine reaches the corneal surface. Methods. Tear fluid samples (50-100 μL) were collected from eight FMF patients on long-term colchicine treatment. Colchicine tear fluid concentrations were determined in all patients by radioimmunoassay using goat anticolchicine antibodies and [3H]colchicine (Dupont, Wilmington, DE). Results. Detectable concentrations of colchicine, with no apparent effect on the ocular surface, were found in all tear fluid samples (median, 0.46 ng/mL; range, 0.24-1.05 ng/mL). Conclusions. This study provides evidence of the route by which colchicine, given systemically, reaches the corneal surface and thus gives credence to the possible inhibitory effect of this drug on corneal wound healing in the cases described in the literature.

Original languageEnglish (US)
Pages (from-to)191-193
Number of pages3
JournalCornea
Volume22
Issue number3
DOIs
StatePublished - Apr 1 2003

    Fingerprint

Keywords

  • Familial Mediterranean fever
  • Peritonitis
  • Pleuritis
  • Tear fluid

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Leibovitch, I., Alster, Y., Scherrmann, J. M., Azmon, B., Barequet, I. S., Livneh, A., O'Brien, T. P., Lazar, M., & Loewenstein, A. (2003). Colchicine in tear fluid of treated patients with familial Mediterranean fever. Cornea, 22(3), 191-193. https://doi.org/10.1097/00003226-200304000-00001